Abstract
An ethnopharmacological investigation was undertaken on Western Ghats plants traditionally used to treat malaria; 50 plants were very carefully selected from total of 372 plants, and 216 extracts were prepared and tested for in vivo antiplasmodial activity alone and in combination with chloroquine (CQ) against CQ-tolerant Plasmodium berghei (strain NK65). In in vivo antiplasmodial activity when plant extract alone is used, 81 extracts (or 37.5%) gave 52.90% significant parasitemia inhibition on day 4 postinfection and 39 extracts (or 18%) gave 41–89% mouse survival on day 9 postinfection. In combination with CQ on day 11 postinfection, 103 extracts (or 47.68%) gave mouse survival rate of 92% and on day 14 gave maximum mouse survival up to 70–79%. The fact that these activities were up to fourfold higher with CQ mostly resulted in longer mouse survival because of significant parasitemia inhibition. Our investigation have confirmed that above 70% of the plant extracts showed moderate to high in vivo antimalarial activity when used alone and in combination with CQ, and most of the extracts showed border line to good synergistic activity.
Introduction
The Western Ghats is known for its richest biodiversity and the area is one of the eight biodiversity hotspots identified in the worldwide. The Western Ghats mountain range stretches for about 1600 km from the south most tip of India in Tamil Nadu from 8°N to 21°N latitudes and 173°E to 77°E longitudes to the river Tapti with the state Maharashtra, and the region covers an area of 1,60,000 sq km supporting a population of more than 50 million people. About 30% area is covered with forest and it is the ecologically richest region of India; of the 15,000 plant species recorded so far, 4000 are endemic to the region. The diverse natural wealth of the region supports numerous tribal communities who harvest nearly 150 uncultivated food plants and more than 500 medicinal plants from the wild. Chloroquine (CQ) continues to play a major role for malaria treatment in primary health care system because of its efficacy and low cost. Unfortunately, the resistant strains of Plasmodium falciparum, the most virulent of the four species infecting humans, have emerged in the past decade, making the discovery of new antimalarial agents with a novel mode of action a global health priority. The malarial multidrug resistant parasites led WHO (2006) to recommend combination therapy as first-line treatment to control malaria globally. In an attempt to impede selection of drug resistance, use of monotherapy is being discouraged for most parasitic diseases (WHO 2000). In the case of malaria, for instance, not only are novel combinations being tried, but also attempts are being made to enhance the potency and/or even reverse resistance of conventional drugs such as CQ (Winstanley 2000). There are no documented data on interactions of herbal remedies with conventional drugs such as CQ. In this study, several Western Ghats plants used as traditional remedies for malaria and malaria-like symptoms in India were evaluated for antimalarial activity against CQ rodent parasite Plasmodium berghei in mice, alone or in combination with the conventional antimalarial drug CQ.
Materials and Methods
Antimalarial plant screening
The tribal communities such as Kaani, Gowlis, Siddis, Halakkiokkaligas, and Kunabis inhabiting the Western Ghats region are one of the richest knowledge systems on tribal medicines in India, as their treatments of diseases are almost entirely confirmed to herbal medicines. An ethnopharmacological investigation of Western Ghats medicinal plants traditionally used against malaria and malaria-like symptoms was undertaken starting from the above tribal communities to their traditional healers called Plathis and was enriched by relevant literature survey and interviews. An inventory of 372 plants was developed. Selection was further optimized to narrow down the identification of potentially new antimalarial compounds. Weighted criteria were applied to this collection based on the quality of documented references, relevance and redundancy of the information, the specific use of the plant to treat malaria or malaria-like symptoms, the convergence of remedies and practices in different parts, chemical composition, and biological activity reports; 50 plants were selected and are listed in Table 1.
R, root; W, whole plant; B, bark; Se, seeds; L, leaves; F, fruits; V.N., voucher number; Rhi, rhizome.
Collection and identification
Plant collection was carried out, starting from mid 2005 from areas spreading out from Kanniyakumari, Kalakad, (TamilNadu) to Palakad through Eravikulam, Idukki (Kerala), Kudremukh, Banavasi, and Udupi (Karnataka). Collections were undertaken from areas endemic for malaria, with variable vegetable covers. Botanic identification was first conducted in the field. The parts of the plant traditionally used were collected and allowed to dry. The specimens were then chopped into small pieces and put on plates in a drying room for 12 h at 40–50°C, until desiccated. Plants were crushed into powder using a hammer mill and stored at room temperature in plastic bags under vacuum with a dehumidifying pellet sachet. The specimen identification was confirmed by the Botanical Survey of India, Tamil Nadu Agricultural University Campus, Coimbatore, India. And by comparison with the Western Ghats flora database system—named “Shayadri-Western Ghats Biodiversity Information System”—developed by the Indian Institute of Science (IISc), Bangalore, India. These voucher herbarium specimens were deposited at the departmental General Library, School of Life Sciences, Bharathiar University, Coimbatore, India.
Extraction
Crude extractions from the plants were performed in the medicinal chemistry laboratory of the School of Life Sciences, Bharathiar University, Coimbatore, India. For each part of the plant, 50 g of powdered dried material was sequentially macerated three times in ethanol 80% for 2 h with constant shaking at room temperature. The filtrates were pooled and evaporated to dryness and the powdered extract was stored in a dry place in dark. Crude extract fractionation was performed with a semiautomatized Soxhlet extractor (Soxhlet Avanti 2055 apparatus). Each crude extract (2 g) was mixed with sand (15 g) and sequentially extracted with 100 mL of cyclohexane (15 min, 180°C) and methanol (60 min, 27°C). The filtrates were taken to dryness under vacuum and the powdered residues were stored at 4°C, and 216 organic extracts were obtained. Extracts were conditioned in 96-tube microplates at a concentration of 10 mg/mL in dimethyl sulphoxide and stored at −20°C.
Biological assays
Experimental mice
For in vivo antimalarial assays of plant extracts a CQ-tolerant P. berghei (strain NK65), a rodent malaria parasite, was used. The blood stage CQ-tolerant-induced parasite was maintained at the parasitic bank of Department of Parasitology, Bharathiar University, Coimbatore, India. Donor mouse for the experimental mice, having 0–15% parasitemia, was sacrificed and bled by cardiac puncture. The parasitemia was adjusted downward using physiological saline, and each of the experimental Swiss albino 7-week-old mice weighing about 32 g was inoculated intraperitoneally with approximately 105 parasitized erythrocytes in volumes of 0.2 mL (Ishih et al. 2003). The infected animals were divided into groups, each group consisting of five animals per cage, and maintained in an animal care facility with commercialized diet and water ad libitum.
In vivo antimalarial assay
For screening of the plant extracts alone, the 4-day suppressive method of Peters et al. (1975) was used. Within 3 h postinoculation of mice with the parasite (i.e., on day 0), treatment of the experimental groups was initiated by oral administration of the test extract, dissolved in an aqueous solution of 0.2% dimethyl sulphoxide (v/v) and diluted to a desired final volume with saline, at a dose of 500 mg/kg body weight and treatment was done twice a day (at 8-h interval) for 4 days, up to day 3 postinfection. A positive control group that received CQ at a dose of 20 mg/kg body weight once a day for 2 days, as well as an untreated control group that received saline only, was also included. All the extracts and combinations were tested in parallel in five independent repetitions. Twenty-four hours after the last treatment (i.e., on day 4 postinfection), parasitemia of individual mouse was determined by microscopic examination of Giemsa-stained thin blood smears prepared from mouse tail blood.
For assessing the in vivo interactions of CQ and the plant extracts, treatment was started on day 4 postinfection based on the method of Ishih et al. (2004). Infected mice were randomized into CQ/plant extract treated groups (CQ 20 mg/kg body weight, once a day for 2 days + plant extract 500 mg/kg body weight, twice a day for 4 days), a CQ-treated positive control group, and an untreated control group, which received water only. For all mice before initial treatment on day 4 postinfection, thin blood smears were prepared, after which CQ dose followed by plant extract dose was administered by oral route. In both studies, in vivo antimalarial activity of the test drugs was assessed by monitoring mouse survival and parasitemia for over a 30-day period.
Data and statistical analysis
Percentage suppression of parasitemia for the plant extracts was calculated as follows: 100 − [(mean parasitemia treated/mean parasitemia control) × 100] (Gessler et al. 1995). For comparison of average parasitemia, one-way analysis of variance and two-tailed Student's t-test were used, with p < 0.05 considered significant.
Ethical approval
Handling of the animals was done in accordance with the Guide for Care and Use of Laboratory Animals, Bharathiar University; this work was approved by the ethical committee for using animals (no. 722/02/a/CPCS EA).
Results
In vivo antiplasmodial activity of plant extract alone
The results of the percentage of parasitemia inhibition for mice on day 4 postinfection and their corresponding survival on day 9 postinfection, relative to controls, are presented in Table 2. From different solvent extractions, 45 cyclohexane extracts showed significant parasitemia inhibitions (p < 0.05), ranging from 40% to 89%, out of which 22 extracts showed most significant parasitemia inhibitions ranging from 52% to 89%, namely Andrographis paniculata Nees. (Acanthaceae), Alstonia scholaris L. (Apocyanaceae), Chromolaena odorata L. (Asteraceae), Vernonia amygdalina Del. (Asteraceae), Mangifera indica L. (Anacardiaceae), Caesalpinia pulcherrima (Caesalpiniaceae), Cannabis sativa var. indica (Cannabaceae), Taraxxacum afficinale Web. (Compositae), Spilanthes oleracea L. (Compositae), Evolvulus alsinoides L. (Convolvulaceae), Kalanchoe pinnata (Crassulaceae), Swertia chrayita (Roxb.ex. Fleming) H.Karst. (Gentianceae), Careya arborea Roxb. (Lecythidaceae), Vanda terrablata (Roxe) Hook.ex.G.Don (Orchidaceae), Piper nigrum (Piperaceae), Citrus sinensis (L) Osbeck (Rutaceae), Datura metel L. (Solanaceae), Costus speciosus (Koening ex retz) J.E.Smith (Zingiberaceae), Dillenia indica L. (Dillieniaceae), Diospyros peregrina (Gaertn) Katlati Gurke. (Ebenaceae), and Euphorbia hirta (Euphorbiaceae).
Statistically significant (p < 0.05).
CQ, chloroquine; CH, cyclohexane; MC, methylene chloride; CE, crude extract; ME, methanol extract; SE, standard error.
Methylene chloride extracts from 26 plant species showed significant parasitemia inhibitions, out of which, 16 plant species, namely A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), V. amygdalina Del.(Asteraceae), C. sativa var. indica (Cannabaceae), S. oleracea L. (Compositae), S. chrayita (Roxb.ex. Fleming) H.Karst. (Gentianceae), Cyperus rotundus L. (Cyperaceae), D. peregrina (Gaertn) Katlati Gurke. (Ebenaceae), E. hirta (Euphorbiaceae), Acalypha siamensis (Euphorbiaceae), S. chrayita (Roxb.ex. Fleming) H.Karst. (Gentianceae), C. arborea Roxb. (Lecythidaceae), V. terrablata (Roxe) Hook.ex.G.Don (Orchidaceae), P. nigrum (Piperaceae), Aegle marmelos (Rutaceae), and D. metel L. (Solanaceae), showed most significant parasitemia suppressions ranging from 53% to 87%. In addition, nine crude extracts, namely A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), V. amygdalina Del. (Asteraceae), M. indica L. (Anacardiaceae), Telfairia occidentalis Hook.F (Cucurbitacea), K. pinnata (Crassulaceae), C. rotundus L. (Cyperaceae), as well as D. peregrina (Gaertn) Katlati Gurke. (Ebenaceae), and 8 out of 12 methanolic extracts, namely A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), V. amygdalina Del. (Asteraceae), C. rotundus L. (Cyperaceae), D. peregrina (Gaertn) Katlati Gurke. (Ebenaceae), E. hirta (Euphorbiaceae), S. chrayita (Roxb.ex. Fleming) H.Karst. (Gentianceae), D. metel L. (Solanaceae), showed most significant parasitemia inhibitions ranging from 62% to 89% and 68% to 90%, respectively.
In contrast, 7 out of 28 plant extracts, namely Acanthus ilicifolius L. (Acanthaceae), Ageratum conyzoides L. (Asteraceae), Tamarindus indica L. (Caesulpiniaceae), Butea monosperma (Lamk)Taub. (Fabaceae), Aloe barbadensis Mill (Liliaceae), Mollugo cerviana Ser. (Molluginaceae), and Bacopa monnieri (L) Pennel (Serophulariaceae), showed nonsignificant parasitemia inhibitions (p > 0.05) ranging from 7% to 39% and/or no activity at all.
Based on day 9 postinfection, relative to untreated controls, 39 extracts (19.5%) showed significant mouse survival, up to a further 2 weeks in some cases. Fourteen cyclohexane extracts of A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), V. amygdalina Del. (Asteraceae), C. pulcherrima (Caesalpiniaceae), C. sativa var. indica (Cannabaceae), T. afficinale Web. (Compositae), E. alsinoides L. (Convolvulaceae), K. pinnata (Crassulaceae), E. hirta (Euphorbiaceae), C. rotundus L. (Cyperaceae), C. arborea Roxb. (Lecythidaceae), P. nigrum (Piperaceae), C. sinensis (L) Osbeck (Rutaceae), and D. metel L. (Solanaceae) showed 43–89% mouse survival, up to a further 14–117 days in some cases. Eleven methylene chloride extracts of A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), V. amygdalina Del. (Asteraceae), C. sativa var. indica (Cannabaceae), T. afficinale Web. (Compositae), C. rotundus L. (Cyperaceae), D. peregrina (Gaertn) Katlati Gurke. (Ebenaceae), E. hirta (Euphorbiaceae), A. siamensis (Euphorbiaceae), S. chrayita (Roxb.ex. Fleming) H.Karst. (Gentianceae), P. nigrum (Piperaceae), and D. metel L. (Solanaceae) showed 41–82% mouse survival. The eight crude and five methanolic extracts of A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), C. rotundus L. (Cyperaceae), D. peregrina (Gaertn) Katlati Gurke. (Ebenaceae), as well as S. chrayita (Roxb.ex. Fleming) H.Karst. (Gentianceae) showed mouse survival of 43–80% and 47–89%, respectively. A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), V. amygdalina Del.(Asteraceae), C. rotundus L. (Cyperaceae), E. hirta (Euphorbiaceae) showed 47–62% and 62–79% mouse survival on days 9 and 16 postinfection, respectively, with sustained effect on day 14 postinfection relative to controls.
In vivo antimalarial activity of plant extracts in combination with CQ
In CQ + plant extract combination studies, the parasitemia levels on day 4 postinfection (before initial treatment) were not different among all groups and microscopic examination of smear on day 9 postinfection detected no parasites; however, the recrudescent parasites reappeared by day 11 postinfection, and hence, parasitemia levels at day 11 postinfection were considered the most significant in assessment of chemoinhibition. Table 2 summarizes the parasitemia inhibitions (%) for mice on day 11 postinfection and the corresponding survival on day 14 postinfection when all mice of CQ-treated control group died. Among four different solvent extractions, 45 cyclohexane extracts of A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), C. odorata L. (Asteraceae), V. amygdalina Del. (Asteraceae), C. rotundus L. (Cyperaceae), D. peregrina (Gaertn) Katlati Gurke. (Ebenaceae), S. chrayita (Roxb.ex. Fleming) H.Karst. (Gentianceae), P. nigrum (Piperaceae), as well as Brucea javanica (L) Mess (Simaroubaceae) in combination with CQ showed significant parasitemia inhibitions ranging from 50% to 92% (p < 0.05) and 28 methylene chloride extracts also showed best activities ranging from 52% to 90%.
The most significant antimalarial activities were exhibited by A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), V. amygdalina Del. (Asteraceae), Caesalpinia pulcherrima (Caesalpiniaceae), C. sativa var. indica (Cannabaceae), T. afficinale Web. (Compositae), E. alsinoides L. (Convolvulaceae), K. pinnata (Crassulaceae), E. hirta (Euphorbiaceae), C. rotundus L. (Cyperaceae), C. arborea Roxb. (Lecythidaceae), P. nigrum (Piperaceae), C. sinensis (L) Osbeck (Rutaceae), as well as D. metel L. (Solanaceae), with significant parasitemia inhibition activities ranging from 89% to 90% by cyclohexane extracts. The methylene chloride extracts of A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), D. peregrina (Gaertn) Katlati Gurke. (Ebenaceae), S. chrayita (Roxb.ex. Fleming) H.Karst. (Gentianceae), v. amygdalina del (Asteraceae) as well as D. metal 1 (solanaceae) also exhibited significant plasmodial activities of 90%, 89%, 65%, 85%, 80%, 86%, and 87%, respectively.
Sixteen crude extracts and 14 methanolic extracts of plants (Table 2) also showed significant parasitemia inhibitions on day 11 postinhibition, ranging from 57% to 91% and 53% to 94%, respectively. Different extractions of the five plants A. ilicifolius L. (Acanthaceae), Chrysanthemum coronarium L. (Asteraceae), T. indica L. (Caesulpiniaceae), B. monosperma (Lamk) Taub. (Fabaceae), and A. barbadensis Mill (Liliaceae) in combination with CQ showed nonsignificant parasitemia inhibition (p > 0.05) activities of up to 39% (Table 2).
Based on day 14 postinfection, when 100% mortality of CQ-alone treated control occurred, mice in the group treated with CQ + methanolic extract of A. paniculata Nees. (Acanthaceae) showed the highest mouse survival of 79% at day 14 postinfection and other extracts showed survival rates ranging from 69% to 77% on day 14 postinfection. A. scholaris L. (Apocyanaceae) showed the highest survival of 70% on day 14 postinfection. The methanolic extracts of A. paniculata Nees. (Acanthaceae) and A. scholaris L. (Apocyanaceae) in combination treatment showed longer mouse survival by up to a further 2 weeks (day 25 postinfection) relative to controls. CQ + D. indica L. (Dillieniaceae) extracts also had sustained effect on day 14 postinfection, ranging from 58% to 63% mouse survival. The crude and methanolic extracts of D. indica L. (Dillieniaceae), E. hirta (Euphorbiaceae), and B. javanica (L) Mess. (Simaroubaceae) in combination with CQ on day 14 postinfection showed mouse survival ranging from 39% to 48.33%, which was not statistically significant (p > 0.05).
Discussion
As shown from the results of the in vivo antiplasmodial studies presented in Table 2, 55 cyclohexane extracts, 26 methyl chloride extracts, 9 crude extracts, and 12 methanolic extracts, representing 70% of the all the 50 plant species screened, showed significant parasitemia suppressions (p < 0.05) on day 4 postinfection, ranging from 40% to 89%, which strongly validate the ethanomedical use of the herbs in management of malaria. The plants A. paniculata Nees. (Acanthaceae), A. scholaris L. (Apocyanaceae), C. odorata L. (Asteraceae), V. amygdalina Del. (Asteraceae), M. indica L. (Anacardiaceae), C. pulcherrima (Caesalpiniaceae), S. oleracea L. (Compositae), E. alsinoides L. (Convolvulaceae), K. pinnata (Crassulaceae), C. rotundus L. (Cyperaceae), D. peregrina (Gaertn) Katlati Gurke. (Ebenaceae), E. hirta (Euphorbiaceae), S. chrayita (Roxb.ex. Fleming) H.Karst. (Gentianceae), C. arborea Roxb. (Lecythidaceae), V. terrablata (Roxe) Hook.ex.G.Don (Orchidaceae), P. nigrum (Piperaceae), A. marmelos (Rutaceae), C. sinensis (L) Osbeck (Rutaceae), D. metel L. (Solanaceae), C. speciosus (Koening ex retz) J.E.Smith (Zingiberaceae), and Rauwolfia serpentina (Zingiberacea) had shown very high in vivo chemosuppression activities and also significant in vitro antiplasmodial activities against both CQ-sensitive and CQ-resistant P. falciparum isolates in a previous study (Kuppusamy and Murugan 2006). The organic bark extracts of A. scholaris L. had shown the highest in vitro inhibition of parasite growth with IC50 values as low as 1.0 μg/mL, (Keawpradub et al. 1999), which is consistent with the findings of this study, in which the methanolic extract showed a remarkable in vivo parasitemia suppression of 90%, which can be compared with the antiplasmodial activities of Vernonia lasiopus, which showed the highest in vitro inhibition of parasitic growth, with IC50 values as low as 1.0 μg/mL, and remarkable in vivo parasitemia suppression of 59.3% with mouse survival rates of 60% on day 4 postinfection when using its root bark extracts (Muregi et al. 2007). The presence and/or quantities of bioactive compounds in plants are influenced by survival factors including seasons, environment, plant part used, intraspecies variations, and plant age (Weenen et al. 1990, Dua et al. 2004) and this may explain the discrepancies observed in in vitro and in vivo activities of plant parts used.
The two Asteraceae plants C. odorata L. and V. amygdalina Del showed the highest in vivo parasitemia suppression, ranging from 60% to 90% with mouse survival rates up to 63%. Many Asteraceae plants have been investigated chemically and found to contain several metabolites including triterpenes, oxygenated sesquiterpenes, flavones, and vernolic acid (Oketch-Rabah 1996). Secondary metabolites of the genus Vernonia and artemisinin, isolated from the Chinese herbs Artemisia annua, belongs to the same class of compounds and has been avidly used in the synthesis of semisynthetic antimalarials effective against multidrug-resistant strains of P. falciparum (Trigg 1989, Oketch-Rabah 1996). It is important to investigate Vernonia species further. The organic extracts of C. rotundus, Diospyrus peregrine, S. chrayita, E. hirta, and Datura metal showed remarkable in vivo plasmodial activity up to 90% in this study. Although not much has been reported in literature about the biological activity of these plants, their leaf decoctions are traditionally used to treat malarial fever, veneral diseases, and rheumatism among other ailments in some parts of India and Congo (Tona et al. 2004). The fact that all the organic extracts of these plants showed remarkable antimalarial activity underscores the need for further investigation of these plants. In some cases, remarkable suppression of parasitemia by extracts translated into either a higher or longer mouse survival on day 9 postinfection or a relatively longer survival with 68% mouse survival on day 11 postinfection. Most of the plants maintained similar suppression levels on days 4 and 11 postinfection, suggesting that the bioactive agents in these plants may have a good onset of action and fast acting. This may suggest that the bioactive compounds in these plants may have an enough half-life, because some antimalarial drugs including artemisinin-based derivatives are known to be fast acting and have an enough half-life.
In contrast, Kalanga pinnata, Argemone Mexicana, and Psidium guajava had shown moderate antiplasmodial activity with longer mouse survival on day 9 postinfection and shorter survival on day 11 postinfection, which mean that high percentage of survival on day 9 postinfection does not translate into considerably longer mouse survival. This may suggest that the bioactive compound in the plant may have a slow onset of action and have a short half-life. On the other hand, some extracts had shown very mild or no parasitemia suppression with short or no mouse survival, implying that other than direct antiplasmodial benefits to the hosts, such as acting as reducing fever, calming convulsions and headache, and possibly even immunostimulatory effects (Dahanukar et al. 2000). In combination with CQ, some of the extracts showed up to threefold better chemosuppression as well as longer mouse survival when compared with CQ-alone treated controls, suggesting synergistic interactions of the two drugs. As expected, high chemosuppression in most cases led to high mouse survival at day 14 postinfection and subsequently a longer mouse survival, as in the case of the group treated with CQ-A. scholaris and V. amygdalina. Some plant extracts such as A. conyzoides, Aristolochia tagala, and Cassia occidentalis, which lacked activity when used alone, demonstrated both higher as well as prolonged mouse survival when used in combination with CQ. As noted earlier, this emphasizes the possibility of other pharmacological effects of plants being involved, besides direct antiparasitic effects. On the other hand, some extracts including C. sativa var. indica and S. oleracea, which had significant activity when used alone, showed little or no suppression in combination with CQ. Antagonistic interactions among drugs as well as toxicity cannot be ruled out in such cases, emphasizing the need to avoid simultaneous use of conventional drugs with natural products before the safety and efficacy of such combinations have been authenticated.
Our investigation on Western Ghats plants, which are used as traditional medicines to treat malaria, has confirmed the fact that about 70% of 50 plants screened, which have not been previously studied until this report, showed moderate to high in vivo antimalarial activity when used alone, and most of the extracts showed enhanced CQ activity, which forms a basis for further detailed studies of these plants, including isolation and characterization of the bioactive compounds, with the ultimate objective of finding novel antimalarial compounds that can be used to fight against the drug-resistant malarial parasites.
Footnotes
Acknowledgments
The authors thank Dr. K. Sasikala (Professor and Head) for her warm support and critical evaluation of the manuscript and Dr. Maruthappan for help with solvent provision and crude extract fractionation. Special thanks to Dr. Gunasekaran for technical help. Warm thanks also to Dr. Ramesh for help with botanical determination.
Disclosure Statement
No competing financial interests exist.
